Medicine and Dentistry
Hepatocellular Carcinoma
100%
Chronic Hepatitis C
85%
Nonalcoholic Fatty Liver
65%
Hepatitis C
59%
Fibrosis
59%
Liver Transplantation
59%
Liver Fibrosis
55%
Liver Cirrhosis
52%
Infection
43%
Liver Disease
40%
Chronic Liver Disease
35%
Liver Graft
33%
Liver Biopsy
30%
Antiviral Therapy
30%
Gene Linkage
23%
Retrospective Cohort Study
21%
Alcohol Consumption
21%
Autoimmune Hepatitis
21%
Fatty Liver
20%
Randomized Controlled Trial
19%
Interferon
18%
Biochemical Marker
18%
Liver Cancer
18%
Hepatitis C Treatment
18%
Decompensated Liver Cirrhosis
17%
Ribavirin
16%
Hepatitis C Virus
15%
Fulminant Hepatic Failure
14%
Restylane
14%
Hazard Ratio
13%
Combination Therapy
12%
Overlap Syndrome
12%
Prevalence
12%
Intoxication
11%
Liver Toxicity
11%
Transplantation
11%
Invasive Aspergillosis
11%
Autoimmune Liver Disease
10%
Cytomegalovirus Infection
10%
Liver Failure
10%
Biological Variation
9%
Acute Graft Versus Host Disease
9%
Compassionate Use
9%
Primary Health Care
9%
Nocardiosis
9%
Triage
9%
Nonstructural Protein 5A Inhibitor
9%
Immunoglobulin G
9%
Malignant Fibrous Histiocytoma
9%
Acute Liver Failure
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
39%
Hepatitis C
23%
Liver Fibrosis
23%
Fibrosis
21%
Chronic Hepatitis C
19%
Biochemical Marker
18%
Hepatitis C Virus
18%
Autoimmune Hepatitis
18%
Nonalcoholic Fatty Liver
14%
Liver Cirrhosis
13%
Cohort Study
12%
Ribavirin
12%
Hepatotoxicity
11%
Toxic Injury
11%
Antiviral Therapy
10%
Myxovirus Resistance Protein A
9%
Implant
9%
Recurrent Disease
9%
Methotrexate
9%
Biological Variation
9%
Liver Cancer
9%
Hyaluronic Acid
9%
Tumor Growth
9%
Naltrexone
9%
All Cause Mortality
9%
Fluorine 18
9%
Viral Clearance
9%
Adverse Outcome
9%
Etanercept
9%
Acute Abdomen
9%
Immunoglobulin G
9%
Yttrium 90
9%
Colchicine
9%
Acute Graft Versus Host Disease
9%
Tumor Necrosis Factor Inhibitor
9%
Liver Disease
9%
Sofosbuvir Plus Velpatasvir Plus Voxilaprevir
9%
Nonstructural Protein 5A Inhibitor
9%
Microsphere
9%
Polyethylene Terephthalate
9%
Mycophenolate Mofetil
9%
Autoimmune Liver Disease
9%
Syndrome
9%
Ethanol
8%
Chronic Liver Disease
7%
Mycophenolic Acid
7%
Alpha 2 Macroglobulin
6%
Side Effect
6%
Multiple Organ Failure
6%
Combination Therapy
6%